Irish biopharmaceutical company Alkermes has begun a randomised Phase II trial to assess the efficacy and safety of ALKS 2680 ...

Idiopathic hypersomnia is a neurological sleep disorder characterised by excessive daytime sleepiness despite getting a full ...

Alkermes plc ALKS announced that it has initiated the phase II Vibrance-3 study, evaluating the novel, investigational and ...

If you find yourself feeling sleepy in the daytime it could be related to a sleep disorder called hypersomnia. So, what is hypersomnia? Unlike insomnia, where you struggle to sleep, hypersomnia ...

Alkermes (ALKS) announced the initiation of Vibrance-3, a phase 2 clinical study evaluating the safety and efficacy of ALKS 2680 compared to ...

With idiopathic hypersomnia, it’s hard to get to a diagnosis, much less an effective treatment. Learn what you need to know to take control of your care.

There remains high unmet need for the idiopathic hypersomnia community, as evidenced by a recent survey conducted by the Sleep Consortium1 in which more than 90% of patients surveyed indicated ...

These quiz questions about idiopathic hypersomnia (IH) are derived from current literature. Are you up to date? At the end of the quiz, compare your score with those of your physician colleagues.

Searching for effective treatment options for 'Hypersomnia symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

Irish biopharmaceutical company Alkermes has begun a randomised Phase II trial to assess the efficacy and safety of ALKS 2680 in adults with idiopathic hypersomnia (IH). The double-blind ...

Secondary endpoints of the Vibrance-3 study are changes in the Idiopathic Hypersomnia Severity Scale score and incidence of adverse events. Year to date, shares of Alkermes have gained 13.1% compa ...

Alkermes plc (Nasdaq: ALKS) today announced the initiation of Vibrance-3, a phase 2 clinical study evaluating the safety and efficacy of ALKS 2680 compared to placebo in adults with idiopathic ...